IRIS
LAZZERINI, PIETRO ENEA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.247
EU - Europa 6.764
AS - Asia 1.304
AF - Africa 54
SA - Sud America 24
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 15.416
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.214
GB - Regno Unito 1.739
IE - Irlanda 1.166
IT - Italia 855
CN - Cina 785
SE - Svezia 698
DE - Germania 589
RU - Federazione Russa 531
UA - Ucraina 527
FR - Francia 320
SG - Singapore 252
FI - Finlandia 170
VN - Vietnam 125
CI - Costa d'Avorio 47
IN - India 47
ES - Italia 44
BE - Belgio 33
TR - Turchia 29
CA - Canada 27
CZ - Repubblica Ceca 21
NL - Olanda 21
TH - Thailandia 19
GR - Grecia 17
BR - Brasile 14
AU - Australia 11
EU - Europa 7
IL - Israele 6
IR - Iran 6
PL - Polonia 5
HK - Hong Kong 4
PK - Pakistan 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CL - Cile 3
EG - Egitto 3
HR - Croazia 3
ID - Indonesia 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
AR - Argentina 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CH - Svizzera 2
DK - Danimarca 2
KG - Kirghizistan 2
KR - Corea 2
KZ - Kazakistan 2
MX - Messico 2
PA - Panama 2
PH - Filippine 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
JP - Giappone 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
NG - Nigeria 1
NO - Norvegia 1
RS - Serbia 1
SA - Arabia Saudita 1
SM - San Marino 1
TM - Turkmenistan 1
ZA - Sudafrica 1
Totale 15.416
Salva come PNG Salva come JPEG
Città #
Southend 1.606
Fairfield 1.169
Dublin 1.133
Ashburn 632
Chandler 599
Woodbridge 543
Houston 448
Jacksonville 424
Wilmington 420
Seattle 416
Cambridge 394
Siena 328
Menlo Park 308
Ann Arbor 291
Princeton 209
Beijing 199
Singapore 166
Nanjing 155
Dong Ket 125
Boardman 97
Dearborn 93
Helsinki 88
Vimercate 78
San Diego 74
New York 69
San Mateo 64
Nanchang 59
Moscow 58
Florence 57
Abidjan 47
Shanghai 43
Shenyang 41
Málaga 40
Brussels 33
Milan 30
Hebei 27
Lancaster 26
London 26
Izmir 24
Tianjin 23
Jinan 21
Kunming 21
Norwalk 21
Toronto 21
Changsha 19
Jiaxing 19
Munich 18
Fremont 17
Hefei 17
San Francisco 17
Falls Church 16
Pune 16
Guangzhou 15
Venezia 15
Düsseldorf 14
Lappeenranta 14
Ningbo 14
Washington 14
Brno 13
Dallas 13
Mestre 13
Zhengzhou 12
Chicago 11
Livorno 11
Los Angeles 11
Redwood City 11
Caserta 10
Columbus 10
Frankfurt am Main 10
Rome 10
Changchun 9
Hangzhou 9
Pisa 9
Taizhou 9
Paris 8
Nicola 7
Olomouc 7
Phoenix 7
Sacramento 7
Aulla 6
Canberra 6
Fuzhou 6
Hounslow 6
Hyderabad 6
Tappahannock 6
Turin 6
Amsterdam 5
Lanzhou 5
Petah Tikva 5
Prato 5
Santa Clara 5
São Paulo 5
Anguillara Sabazia 4
Arezzo 4
Clifton 4
Grosseto 4
Modena 4
Ottawa 4
Queens 4
Sinalunga 4
Totale 11.282
Salva come PNG Salva come JPEG
Nome #
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 286
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 257
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 249
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 237
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 232
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 232
P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism? 230
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 220
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 212
Antiarrhythmic potential of anti-cytokine therapy in rheumatoid arthritis: Tocilizumab reduces QTc interval by controlling systemic inflammation. 212
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 205
Torsades de Pointes in patients with polymyalgia rheumatica 201
Antirheumatic agents in covid-19: is IL-6 the right target? 198
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 193
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 186
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 182
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 180
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 176
Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients 175
Statins and the joint: multiple targets for a global protection? 173
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 171
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 164
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 161
Connective tissue diseases and cardiac rhythm disorders: an overview 160
How to Identify Patients at Risk of Silent Atrial Fibrillation after Cryptogenic Stroke: Potential Role of P Wave Dispersion 156
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 155
Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis 155
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 154
The role of P2X7 receptors in tissue fibrosis: a brief review 153
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 152
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 151
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 150
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 149
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases 148
T lymphocytes as targets of statins: molecular mechanisms and therapeutic perspectives 147
Previous use of statins and atrial electrical remodeling in patients with cryptogenic stroke 147
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 147
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 146
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 145
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 141
null 141
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 141
Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats 141
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 141
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 141
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 140
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 139
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 138
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 134
Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities 134
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 132
Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. 132
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 130
Homocysteine and Raynaud’s phenomenon: a review 130
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 129
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 129
Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients. 126
null 126
Atrial cardiopathy and sympatho-vagal imbalance in cryptogenic stroke: Pathogenic mechanisms and effects on electrocardiographic markers 126
null 124
Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression 124
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 124
Human rheumatoid synoviocytes express functional P2X7 receptors 123
null 122
null 122
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts 121
Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies 121
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 120
Statins as a new therapeutic perspective in myocarditis and postmyocarditis dilated cardiomyopathy 119
Pathogenesis of the novel autoimmune-associated long-QT syndrome 119
Corrected QT interval in anti-SSA-positive adults with connective tissue disease: Comment on the article by Lazzerini et al. [6] (multiple letters) 117
Comment on: Letter to the Editor from Clockaerts and Bierma-Zeinstra 116
Potassium Channel Block and Novel Autoimmune-Associated Long QT Syndrome 116
Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies 116
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 115
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 114
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 113
Photopheresis immunomodulation after heart transplantation. 110
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 110
Long QT Syndrome: An Emerging Role for Inflammation and Immunity 109
Simvastatin reduces MMP-3 level in interleukin 1b-stimulated human chondrocyte culture 107
null 105
Homocysteine and P wave dispersion in patients with heart transplantation 104
Hyperhomocysteinemia: a cardiovascular risk factor in autoimmunediseases? 104
Alteration in the redox state of plasma in heart transplanted patients with moderate hyperhomocisteinemia 102
P wave dispersion and silent atrial fibrillation in cryptogenic stroke: The pathogenic role of inflammation 102
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 100
Le indicazioni al trattamento con immunoglobuline endovena nelle malattie reumatiche. [Indications for intra-venous immunoglobulin treatment in rheumatic diseases] 100
Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1beta-stimulated synoviocytes from rheumatoid arthritis patients 99
Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes 99
Hyperhomocysteinemia, inflammation and autoimmunity 96
Blunted increase in plasma adenosine levels following dipyridamole stress test in dilated cardiomyopathy patients 94
Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?” 94
Effects of acute administration of iloprost on the cardiac autonomic nervous system and ventricular repolarisation in patients with systemic sclerosis 93
Commentary: Systemic effects of IL-17 in inflammatory arthritis 85
Neutrophil extracellular traps release in gout and pseudogout depends on the number of crystals regardless of leukocyte count 85
Electrocardiographic Predictors of Silent Atrial Fibrillation in Cryptogenic Stroke 81
Risk of qtc interval prolongation associated with circulating anti-ro/ssa antibodies among us veterans: an observational cohort study 76
Upregulation of A2A adenosine receptor expression by TNFa in PBMC of patients with CHF: a regulatory mechanism of inflammation 74
COVID-19, Arrhythmic Risk, and Inflammation: Mind the Gap! 73
Totale 14.186
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.102
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.102
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.044 0 0 0 0 191 316 341 389 254 265 114 174
2020/20212.517 127 216 96 258 123 284 168 301 300 220 208 216
2021/20221.894 135 220 91 146 130 55 91 146 142 167 196 375
2022/20232.267 144 244 310 318 179 435 78 160 228 65 60 46
2023/20241.995 69 39 149 100 94 534 607 61 33 46 78 185
2024/2025983 89 201 365 256 72 0 0 0 0 0 0 0
Totale 15.764